AG 013736,
AG-013736,
AG013736,
axitinib,
inlyta,
Axitinib,
319460-85-0,
AG-013736,
Inlyta,
AG 013736,
axitinibum,
UNII-C9LVQ0YUXG,
AG013736,
C9LVQ0YUXG,
N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide,
(E)-N-Methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide,
AG-13736,
CHEBI:66910,
MFCD09837898,
NSC757441,
N-methyl-2-({3-[(E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide,
NCGC00241108-01,
S1005,
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamide,
DSSTox_CID_28975,
DSSTox_RID_83240,
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide,
DSSTox_GSID_49049,
Axitinib (AG 013736),
C22H18N4OS,
N-methyl-2-({3-[(E)-2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide,
CAS-319460-85-0,
Axitinib [USAN:INN:JAN],
4agc,
Inlyta (TN),
AG13736,
4ag8,
Axitinib (JAN/USAN),
Axitinib/AG013736,
AG-013736;Axitinib,
Axitinib,AG-013736,
cc-356,
MLS006010164,
SCHEMBL172918,
AC1O51X3,
GTPL5659,
Axitinib, >=98% (HPLC),
CHEMBL1289926,
DTXSID3049049,
BDBM25117,
CHEBI:94568,
EX-A337,
QCR-109,
SYN1014,
BCPP000372,
AOB87786,
BCP01371,
ZINC3816287,
Tox21_113597,
ABP000115,
AN-501,
AKOS015902898,
Tox21_113597_1,
AC-1539,
BCP9000345,
CS-0116,
DB06626,
KS-1448,
NSC-757441,
RL03128,
SB20061,
NCGC00241108-04,
NCGC00241108-06,
4CA-0215,
AJ-45709,
BC659937,
CJ-10777,
HY-10065,
SC-22491,
SMR002530046,
AB0008632,
TR-013491,
AM20090673,
SW219464-1,
A10103,
D03218,
Q-3279,
AB01274739-01,
AB01274739_02,
460A850,
SR-01000941566,
I14-1971,
J-502064,
Q-200662,
SR-01000941566-1,
BRD-K29905972-001-01-4,
BRD-K29905972-001-02-2,
Axitinib|319460-85-0|AG 013736|AG013736,
Benzamide, N-methyl-2-((3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazo)-6-yl)thio)-,
Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-,
N-Methyl-[[3[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-benzamide,
N-methyl-2-({3-[(E)-2-pyridin-2-ylethenyl]-2H-indazol-6-yl}sulfanyl)benzamide,
N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)-BENZAMIDE,
N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-1H-indazol-6-yl]sulfanyl]benzamide,
Avobenzone,
Axitinib?,
Axitinib [USAN],
D01ZRI,
Axitinib (VEGFR inhibitor),
AG-013736, Axitinib,
Axitinib, 98% - 50MG 50mg,
ACN-036288,
CID6450551,
CS-T-04381,
C503983,
D000077784,
319463-51-9,
Benzamide, N-methyl-2-((3-((E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)-,
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide,
AXI,